Tenet Healthcare (NYSE:THC) Price Target Raised to $265.00 at Mizuho

Tenet Healthcare (NYSE:THC) had its price target boosted by Mizuho from $235.00 to $265.00 in a research report released on Thursday,Benzinga reports. The firm currently has an outperform rating on the stock.

THC has been the subject of a number of other reports. Royal Bank Of Canada increased their price target on Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research report on Thursday, February 12th. Morgan Stanley restated an “overweight” rating and issued a $260.00 target price on shares of Tenet Healthcare in a research note on Thursday, February 12th. Truist Financial boosted their target price on shares of Tenet Healthcare from $240.00 to $270.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. Wall Street Zen upgraded shares of Tenet Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Sunday, March 1st. Finally, Weiss Ratings raised shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and an average target price of $250.56.

Tenet Healthcare Stock Down 4.2%

Shares of NYSE THC opened at $224.68 on Thursday. The company’s fifty day simple moving average is $212.89 and its 200 day simple moving average is $203.65. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $247.21. The company has a quick ratio of 1.68, a current ratio of 1.76 and a debt-to-equity ratio of 2.18. The firm has a market cap of $19.54 billion, a PE ratio of 14.50, a P/E/G ratio of 1.15 and a beta of 1.39.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same quarter in the prior year, the company earned $3.44 earnings per share. The company’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. As a group, sell-side analysts forecast that Tenet Healthcare will post 12.24 earnings per share for the current fiscal year.

Insider Transactions at Tenet Healthcare

In related news, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Nadja West sold 2,178 shares of Tenet Healthcare stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares of the company’s stock, valued at $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 42,195 shares of company stock valued at $9,823,406 in the last ninety days. 0.81% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently made changes to their positions in the business. Norges Bank bought a new position in Tenet Healthcare in the 4th quarter worth $248,494,000. Eminence Capital LP purchased a new stake in Tenet Healthcare during the third quarter valued at $225,263,000. Boston Partners lifted its stake in shares of Tenet Healthcare by 95.0% in the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares during the last quarter. Wellington Management Group LLP boosted its stake in shares of Tenet Healthcare by 1,114.2% during the 4th quarter. Wellington Management Group LLP now owns 1,135,801 shares of the company’s stock worth $225,706,000 after purchasing an additional 1,042,260 shares during the period. Finally, AQR Capital Management LLC raised its holdings in shares of Tenet Healthcare by 62.3% in the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after buying an additional 720,160 shares during the period. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.